Bitget GetAgent Playbook Expands to US Stocks, Launches AI Stock Selection and Automated US Stock Trading Strategies
Foresight News reported that Bitget announced the expansion of its GetAgent Playbook, incorporating US stocks into its AI strategy system and providing users with AI stock selection and automatic order placement features. The GetAgent Playbook was launched in June 2026, allowing users to browse, subscribe to, and deploy preset strategies with one click. In its first week online, the product had over 30,000 unique users, with cumulative principal investments exceeding $100,000. More than 600 users created personalized strategies, and the highest single account yield reached 145%.
This update to the US stocks section introduces several new strategies, covering both selection and execution aspects. Stock-picking strategies include AI Picks, High-Quality Business Mode Screening, Beta Growth Investing, Macro Event-Driven Approaches, and Analyst Rating Tracking. For automatic order placement, the platform now offers QQQ Smart DCA, supporting execution of DCA strategies by fixed amount and fixed interval, helping users diversify entry costs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.
The White House did not intervene in the decision-making of Nvidia's board of directors.
Crypto prices
More
